[The problem of quality of medications at Russian market (1992-2004). Report II. The control of new and serially produced medications].

Abstract

The archives of the Ministry of Health Care of Russia, journal publications, interviews and memoirs testify that issue of medications quality was key issue in life of Russian Pharma in 1992-2004. The support of medication safety considered not only as part of social policy, but also as rules that could be used to reformat the "wild bazaar" into "controlled market". The media disputes, departmental justifications, political bills and memoirs give idea about "price of the issue" (heat of emotions, ambitions, financial losses). Besides, depending on who would determine quality (and thus to evaluate all players of Pharma market) depended placement of center of power in market. The authors of the study present in series of reports results of historical reconstruction of building materials, architects and technologies of construction of Russian control and authorization-based system and market rules. This report deals with practices of expertise of new and serially produced medications.